Skip to content
  • Sunday, 26 July 2026
  • 7:56 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • TWiV 1284: Clinical update with Dr. Daniel Griffin
Microbiology & Immunology

TWiV 1284: Clinical update with Dr. Daniel Griffin

Lina Irawan Jun 15, 2026 0

In a timely post-New Year’s Day discussion, This Week in Virology (TWiV) episode 1284 features Dr. Daniel Griffin, a practicing…

Read More
Microbiology & Immunology

TWiV 1285: Encapsidating Viruses 2025

Lina Irawan Jun 15, 2026 0

This Week in Virology (TWiV), a prominent podcast in the scientific community, has released its 1285th episode, offering a retrospective…

Read More
Microbiology & Immunology

TWiV 1286: Clinical Update with Dr. Daniel Griffin Addresses Alarming Shifts in Public Health Discourse and Data

Lina Irawan Jun 15, 2026 0

In a recent episode of "This Week in Virology" (TWiV), Dr. Daniel Griffin, alongside host Vincent Racaniello, expressed profound bewilderment…

Read More
Microbiology & Immunology

TWiV 1287: Ancient Herpesviruses and Modern Dementia

Lina Irawan Jun 15, 2026 0

This Week in Virology (TWiV) episode 1287, released on January 11, 2026, delves into two significant areas of viral research:…

Read More
Microbiology & Immunology

TWiV 1288: Clinical update with Dr. Daniel Griffin

Lina Irawan Jun 14, 2026 0

In a recent clinical update, Dr. Daniel Griffin, alongside Vincent Racaniello, expressed profound bewilderment and dismay regarding announced changes to…

Read More
Microbiology & Immunology

TWiV 1289: Building a better hepatitis B trap

Lina Irawan Jun 14, 2026 0

This Week in Virology (TWiV) episode 1289 delves into two significant advancements in virology: the intricate mechanisms by which the…

Read More
Microbiology & Immunology

TWiV 1290: Clinical Update with Dr. Daniel Griffin Delves into Infectious Disease Trends and Public Health Strategies

Lina Irawan Jun 14, 2026 0

In his latest clinical update on "This Week in Virology" (TWiV) episode 1290, Dr. Daniel Griffin provided a comprehensive overview…

Read More
Microbiology & Immunology

A Foot in the Door for Cytomegalovirus

Lina Irawan Jun 14, 2026 0

The latest episode of "This Week in Virology" (TWiV) delves into two critical advancements in virology: the emergence of a…

Read More
Microbiology & Immunology

TWiV 1292: Clinical update with Dr. Daniel Griffin

Lina Irawan Jun 13, 2026 0

The recent weekly clinical update on "This Week in Virology" (TWiV) podcast, hosted by Vincent Racaniello and featuring Dr. Daniel…

Read More
Microbiology & Immunology

TWiV 1293: The enemy of your parasite is your friend

Lina Irawan Jun 13, 2026 0

This Week in Virology (TWiV) podcast episode 1293, released on February 1, 2026, delves into two significant scientific discoveries with…

Read More

Posts pagination

1 … 5 6 7 … 19
TWiV 1288: Clinical update with Dr. Daniel GriffinUnlocking the Hidden Language of Life: New Statistical Approach Promises Breakthroughs in AstrobiologyStanford Researchers Pioneer Non-Invasive Ultrasound Technology to Generate Therapeutic Light Within Deep Body TissuesSeven Pharma Companies Selected for FDA PreCheck Pilot Program to Bolster U.S. Drug Supply Chain
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ